Women’s health imaging solutions from Hologic which aid in cancer detection and radiologist workflow were part of the Radiological Society of North America Scientific Sessions and Annual Meeting, RSNA 2023, held this week in Chicago. Image courtesy: Hologic
November 30, 2023 — Hologic, Inc. showcased several recent developments in next-generation AI solutions at the 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America, RSNA 2023 which was held from Nov. 26 to 30 in Chicago, IL. On the show floor and during multiple workshops, the global leader in breast imaging unveiled advances that leverage AI to improve cancer detection, workflow and patient satisfaction.
New to Hologic’s portfolio of Breast and Skeletal Health Solutions: Genius AI Detection 2.0 solution, a next-generation deep-learning technology designed to improve breast cancer detection while reducing the number of false-positive markings per case. With more than a 70% reduction in false-positive markings per case when compared to Hologic’s ImageChecker CAD solution, Genius AI Detection 2.0 technology gives radiologists confidence that marked lesions are truly suspicious and warrant further review.1 Additionally, the new SecurView 12.0 solution enables more multimodality capabilities, including reading breast ultrasound cases directly in the SecurView viewer. When paired with Genius AI Detection 2.0, the new automated lesion correlation feature is enabled to allow for faster review of specific lesions, according to a company overview.
“We are building on our history of innovation in breast health with an exciting new AI-based solution that is designed to support the radiologist with improved cancer detection and a more efficient workflow — two factors that we know are critical for our customers,” said Erik Anderson, Division President, Breast and Skeletal Health Solutions, Hologic, adding, “At this year’s RSNA meeting, we’re looking forward to engaging with industry leaders and affirming our commitment to advancing breast health through cutting-edge technology.”
Genius AI Detection 2.0 technology represents Hologic’s continued commitment to advancing and refining its AI roadmap. Customer feedback, research findings and continuous improvements will inform future iterations of Genius AI Detection technology, as well as new AI products. Hologic is currently exploring new product features to drive toward even greater accuracy and efficient breast care, including:
- Real-time image quality and positioning feedback.
- Short-term risk evaluations.
- Automated reporting tools.
- Smart triage features.
Guests experienced Hologic’s comprehensive portfolio, including the Dimensions mammography portfolio, Affirm Contrast Biopsy software, I-View Contrast Enhanced Mammography software and a full suite of breast biopsy and surgery solutions. Additionally, the Company hosted a CME-accredited symposium and lunch-and-learn sessions, including:
- Advancements in Breast Imaging with Contrast-Enhanced Mammography
- AI Applications in Mammography Today
- A Comprehensive Approach to Localization: Understanding the Benefits of Wire vs. Wire-free Breast Localization Featuring
For more information: www.hologic.com
1 Kshirsagar, A. (2023). Comparison between ImageChecker CAD and GAID algorithm on sequestered FDA database. Refer to Hologic document (DHM-14593).
January 27, 2026 
